CV Sciences, Inc. (CVSI)

OTCMKTS: CVSI · Delayed Price · USD
0.0858
-0.0039 (-4.35%)
Jun 14, 2024, 3:07 PM EDT - Market closed
Market Cap 14.00M
Revenue (ttm) 15.86M
Net Income (ttm) -3.23M
Shares Out 163.23M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 15.63
Dividend n/a
Ex-Dividend Date n/a
Volume 108,500
Open 0.0899
Previous Close 0.0897
Day's Range 0.0840 - 0.0899
52-Week Range 0.0300 - 0.1000
Beta 0.60
Analysts n/a
Price Target n/a
Earnings Date Aug 14, 2023

About CVSI

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for... [Read more]

Sector Healthcare
CEO Joseph D. Dowling
Employees 42
Stock Exchange OTCMKTS
Ticker Symbol CVSI
Full Company Profile

Financial Performance

Financial Statements

News

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

4 weeks ago - PRNewsWire

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc.  (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

4 weeks ago - PRNewsWire

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

SAN DIEGO , May 8, 2024 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...

5 weeks ago - PRNewsWire

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...

2 months ago - PRNewsWire

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN DIEGO , March 26, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company...

2 months ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

SAN DIEGO , March 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals an...

3 months ago - PRNewsWire

CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution

SAN DIEGO , Dec. 12, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

6 months ago - PRNewsWire

CV Sciences, Inc. Reports Third Quarter 2023 Financial Results

SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

7 months ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023

SAN DIEGO , Nov. 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...

7 months ago - PRNewsWire

CV Sciences, Inc. Launches Reserve Sleep Gummies

Premium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "...

10 months ago - PRNewsWire

CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

10 months ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

SAN DIEGO , Aug. 1, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

11 months ago - PRNewsWire

CV Sciences to Participate in LD Micro Invitational Conference

13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO , June 1, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), ...

1 year ago - PRNewsWire

CV Sciences, Inc. Reports First Quarter 2023 Financial Results

SAN DIEGO , May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023

SAN DIEGO , May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and oth...

1 year ago - PRNewsWire

CV Sciences, Inc. Introduces New THC Offering

+PlusCBD™ Reserve Collection Extra Gummies provide easy-to-dose 5mg THC option SAN DIEGO , April 3, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "w...

1 year ago - PRNewsWire

CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results

SAN DIEGO , March 29, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...

1 year ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

SAN DIEGO , March 24, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...

1 year ago - PRNewsWire

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

The Company is seeking strategic opportunities to advance the development of this program SAN DIEGO , March 23, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our...

1 year ago - PRNewsWire

CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels

+PlusCBD™Daily Balance THC-Free products provide benefits of CBD without effects of THC SAN DIEGO , March 21, 2023 /PRNewswire/ --  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",...

1 year ago - PRNewsWire

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

SAN DIEGO , March 2, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

Smaller bottle allows for consumers flexibility at a more affordable price SAN DIEGO , Jan. 19, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we")...

1 year ago - PRNewsWire

CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

SAN DIEGO , Nov. 14, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ...

1 year ago - PRNewsWire

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

SAN DIEGO , Nov. 8, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, ...

1 year ago - PRNewsWire

CV Sciences, Inc. Extinguishes Convertible Debt

SAN DIEGO , Aug. 25, 2022 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...

1 year ago - PRNewsWire